·Reduce unnecessary hospital admissions by identifying women at low risk

·Minimize inappropriate repeat testing and address documentation gaps

 

Over a period of 16 months all women who were high risk for preeclampsia underwent PLGF testing at QEH.

 Patient notes were reviewed retrospectively to audit current practice against NICE DG 23

 

1. 117 PlGF tests were performed in  QEH out of 150 high risk women for preeclampsia making compliance 78%.

2.14 women PLGF<12, 36 had PLGF between 12-100 and 67 had PLGF >100 who were discharged back to routine care .

3.12 overnight admissions were avoided .

4. 90% of results of PLGF and PET bloods were available in 24 hours.

5. 17 women were tested more than once.

6.80% had clear documentation and appropriate management plans.

The audit revealed significant gaps in  implementation of PlGF testing when compared to NICE standards.

71% of women with PLGF<12 had an adverse pregnancy outcome suggesting PLGF is predicting these consequences.

Overnight hospital stays were avoided in many cases .

Moving forward, improving team education, integrating PLGF testing into existing workflow, and enhancing documentation practices are crucial to optimizing the use of PlGF testing.